Carboxypeptidase M in apoptosis, adipogenesis and cancer

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 306-316

  Denis, Catherine J ^a   Deiteren, Kathleen ^a   Hendriks, Dirk ^a   Proost, Paul ^b   Lambeir, Anne Marie ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Adipocyte; Biomarker; Chemokine; Inflammation; Peptide; Protease

Indexed keywords

BRADYKININ B1 RECEPTOR; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE M; CCL1 CHEMOKINE; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; PROTEIN MDM2; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADIPOGENESIS; APOPTOSIS; CANCER PROGNOSIS; CHROMOSOMAL LOCALIZATION; CHROMOSOME 12Q; CPM GENE; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME ASSAY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOASSAY; KIDNEY CARCINOMA; LIPOSARCOMA; LUNG ADENOCARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MDM2 GENE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; STROMA CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ADIPOGENESIS; APOPTOSIS; GENE EXPRESSION; GPI-LINKED PROTEINS; HUMANS; LIPOSARCOMA; LUNG NEOPLASMS; METALLOENDOPEPTIDASES; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SOFT TISSUE NEOPLASMS; SUBSTRATE SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84875080032     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.11.012     Document Type: Review

References (112)

1. Deiteren K., Hendriks D., Scharpé S., Lambeir A.M. Carboxypeptidase M: multiple alliances and unknown partners. Clin Chim Acta 2009, 399:24-39.
2. Park J.J., Koshimizu H., Loh Y.P. Biogenesis and transport of secretory granules to release site in neuroendocrine cells. J Mol Neurosci 2009, 37:151-159.
3. Kalinina E., Fontenele-Neto J.D., Fricker L.D. Drosophila S2 cells produce multiple forms of carboxypeptidase D with different intracellular distributions. J Cell Biochem 2006, 99:770-783.
4. Novikova E., Fricker L.D., Reznik S.E. Metallocarboxypeptidase Z is dynamically expressed in mouse development. Mech Dev 2001, 102:259-262.
5. Mueller-Ortiz S.L., Wang D., Morales J.E., Li L., Chang J.Y., Wetsel R.A. Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock. J Immunol 2009, 182:6533-6539.
6. Tan F., Deddish P.A., Skidgel R.A. Human carboxypeptidase M. Methods Enzymol 1995, 248:663-675.
7. Schatteman K.A., Goossens F.J., Scharpe S.S., Neels H.M., Hendriks D.F. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma. Clin Chem 1999, 45:807-813.
8. Willemse J., Leurs J., Verkerk R., Hendriks D. Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate. Anal Biochem 2005, 340:106-112.
9. Deiteren K., Surpateanu G., Gilany K., et al. The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over. Biochim Biophys Acta 2007, 1774:267-277.
10. Zhang X., Tan F., Zhang Y., Skidgel R.A. Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient b1 signaling from B2 agonists. J Biol Chem 2008, 283:7994-8004.
11. Yoshioka S., Fujiwara H., Yamada S., et al. Membrane-bound carboxypeptidase-M is expressed on human ovarian follicles and corpora lutea of menstrual cycle and early pregnancy. Mol Hum Reprod 1998, 4:709-717.
12. Nishioka Y., Higuchi T., Sato Y., et al. Human migrating extravillous trophoblasts express a cell surface peptidase, carboxypeptidase-M. Mol Hum Reprod 2003, 9:799-806.
13. Julow J., Szeifert G.T., Balint K., Nyary I., Nemes Z. The role of microglia/macrophage system in the tissue response to I-125 interstitial brachytherapy of cerebral gliomas. Neurol Res 2007, 29:233-238.
14. Julow J., Szeifert G.T., Balint K., Nyary I., Nemes Z. Tissue response to iodine-125 interstitial brachytherapy of cerebral gliomas. Prog Neurol Surg 2007, 20:312-323.
15. Tsakiris I., Soos G., Nemes Z., et al. The presence of carboxypeptidase-M in tumour cells signifies epidermal growth factor receptor expression in lung adenocarcinomas: the coexistence predicts a poor prognosis regardless of EGFR levels. J Cancer Res Clin 2008, 134:439-451.
16. Rehli M., Krause S.W., Kreutz M., Andreesen R. Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation. J Biol Chem 1995, 270:15644-15649.
17. de Saint-Vis B., Cupillard L., Pandrau-Garcia D., et al. Distribution of carboxypeptidase M on lymphoid and myeloid cells parallels the other zinc-dependent proteases CD10 and CD13. Blood 1995, 86:1098-1105.
18. Galibert L., Burdin N., de Saint-Vis B., et al. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J Exp Med 1996, 183:77-85.
19. Nagae A., Abe M., Becker R.P., Deddish P.A., Skidgel R.A., Erdos E.G. High concentration of carboxypeptidase M in lungs: presence of the enzyme in alveolar type I cells. Am J Respir Cell Mol 1993, 9:221-229.
20. Dragovic T., Schraufnagel D.E., Becker R.P., Sekosan M., Votta-Velis E.G., Erdos E.G. Carboxypeptidase M activity is increased in bronchoalveolar lavage in human lung disease. Am J Respir Crit Care 1995, 152:760-764.
21. Nagae A., Deddish P.A., Becker R.P., et al. Carboxypeptidase M in brain and peripheral nerves. J Neurochem 1992, 59:2201-2212.
22. Forbes B., Wilson C.G., Gumbleton M. Temporal dependence of ectopeptidase expression in alveolar epithelial cell culture: implications for study of peptide absorption. Int J Pharm 1999, 180:225-234.
23. Rehli M., Krause S.W., Andreesen R. The membrane-bound ectopeptidase CPM as a marker of macrophage maturation in vitro and in vivo. Adv Exp Med Biol 2000, 477:205-216.
24. Kas K., Schoenmakers E.F., Van de Ven W.J. Physical map location of the human carboxypeptidase M gene (CPM) distal to D12S375 and proximal to D12S8 at chromosome 12q15. Genomics 1995, 30:403-405.
25. Erickson-Johnson M.R., Seys A.R., Roth C.W., et al. Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma. Mod Pathol 2009, 22:1541-1547.
26. Scherer S.E., Muzny D.M., Buhay C.J., et al. The finished DNA sequence of human chromosome 12. Nature 2006, 440:346-351.
27. Bektas A., Hughes J.N., Warram J.H., Krolewski A.S., Doria A. Type 2 diabetes locus on 12q15. Further mapping and mutation screening of two candidate genes. Diabetes Diabetes 2001, 50:204-208.
28. Li J., Rehli M., Timblin B., Tan F., Krause S.W., Skidgel R.A. Structure of the human carboxypeptidase M gene. Identification of a proximal GC-rich promoter and a unique distal promoter that consists of repetitive elements. Gene 2002, 284:189-202.
29. Pessoa L.G., da Silva I.D., Baptista H.A., et al. Molecular structure and alternative splicing of the human carboxypeptidase M gene. Biol Chem 2002, 383:263-269.
30. Tan F., Chan S.J., Steiner D.F., Schilling J.W., Skidgel R.A. Molecular cloning and sequencing of the cDNA for human membrane-bound carboxypeptidase M. Comparison with carboxypeptidases A, B, H, and N. J Biol Chem 1989, 264:13165-13170.
31. Guimaraes A.O., Motta F.L., Alves V.S., Castilho B.A., Pesquero J.B. Multiple RNAs from the mouse carboxypeptidase M locus: functional RNAs or transcription noise?. BMC Mol Biol 2009, 10:7.
32. Mallardo M., Poltronieri P., D'Urso O.F. Non-protein coding RNA biomarkers and differential expression in cancers: a review. J Exp Clin Cancer Res 2008, 27:19.
33. Gibb E.A., Brown C.J., Lam W.L. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011, 10:38.
34. Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980, 32:1-46.
35. Stewart J.M. Bradykinin antagonists: discovery and development. Peptides 2004, 25:527-532.
36. Campbell D.J. The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol 2001, 28:1060-1065.
37. Skidgel R.A., Stanisavljevic S., Erdos E.G. Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells. Biol Chem 2006, 387:159-165.
38. Zhang X., Tan F., Brovkovych V., Zhang Y., Skidgel R.A. Cross-talk between carboxypeptidase M and the kinin B1 receptor mediates a new mode of G protein-coupled receptor signaling. J Biol Chem 2011, 286:18547-18561.
39. Marquez-Curtis L.A., Turner A.R., Sridharan S., Ratajczak M.Z., Janowska-Wieczorek A. The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes. Stem Cell Rev 2011, 7:590-607.
40. Denis C., Deiteren K., Mortier A., et al. C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity. PLoS One 2012, 7:e34199.
41. Van Snick J., Houssiau F., Proost P., Van Damme J., Renauld J.C. I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis. J Immunol 1996, 157:2570-2576.
42. Louahed J., Struyf S., Demoulin J.B., et al. CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/CCL1 and vMIP-I. Eur J Immunol 2003, 33:494-501.
43. Spinetti G., Bernardini G., Camarda G., et al. The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway. J Leukoc Biol 2003, 73:201-207.
44. Bernardini G., Spinetti G., Ribatti D., et al. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood 2000, 96:4039-4045.
45. Hoelzinger D.B., Smith S.E., Mirza N., Dominguez A.L., Manrique S.Z., Lustgarten J. Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses. J Immunol 2010, 184:6833-6842.
46. Burns J.M., Summers B.C., Wang Y., et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006, 203:2201-2213.
47. Yu L., Cecil J., Peng S.B., et al. Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene 2006, 374:174-179.
48. Davis D.A., Singer K.E., De La Luz Sierra M., et al. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood 2005, 105:4561-4568.
49. De La Luz Sierra M., Yang F., Narazaki M., et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood Blood 2004, 103:2452-2459.
50. Tan Y., Du J., Cai S., et al. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity. Exp Hematol 2006, 34:1553-1562.
51. Marquez-Curtis L., Jalili A., Deiteren K., Shirvaikar N., Lambeir A.M., Janowska-Wieczorek A. Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization?. Stem Cells 2008, 26:1211-1220.
52. Andreesen R., Gadd S., Costabel U., et al. Human macrophage maturation and heterogeneity: restricted expression of late differentiation antigens in situ. Cell Tissue Res 1988, 253:271-279.
53. Ichikawa Y., Hirokawa M., Aiba N., et al. Monitoring the expression profiles of doxorubicin-resistant K562 human leukemia cells by serial analysis of gene expression. Int J Hematol 2004, 79:276-282.
54. Jackman H.L., Tan F., Schraufnagel D., et al. Plasma membrane-bound and lysosomal peptidases in human alveolar macrophages. Am J Respir Cell Mol 1995, 13:196-204.
55. Nagy B., Soos G., Nagy K., Dezso B. Natural course of isolated pulmonary langerhans' cell histiocytosis in a toddler. 3-year follow-up. Respiration 2008, 75:215-220.
56. Liu T.M., Martina M., Hutmacher D.W., Hui J.H., Lee E.H., Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 2007, 25:750-760.
57. Howell S., Caswell A.M., Kenny A.J., Turner A.J. Membrane peptidases on human osteoblast-like cells in culture: hydrolysis of calcitonin and hormonal regulation of endopeptidase-24.11. Biochem J 1993, 290(Pt. 1):159-164.
58. Salasznyk R.M., Klees R.F., Westcott A.M., Vandenberg S., Bennett K., Plopper G.E. Focusing of gene expression as the basis of stem cell differentiation. Stem Cells Dev 2005, 14:608-620.
59. Bennett K.P., Bergeron C., Acar E., et al. Proteomics reveals multiple routes to the osteogenic phenotype in mesenchymal stem cells. BMC Genomics 2007, 8:380.
60. Filippov V., Filippova M., Duerksen-Hughes P.J. The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes. Cancer Res 2007, 67:7621-7630.
61. Monroe D.G., Getz B.J., Johnsen S.A., Riggs B.L., Khosla S., Spelsberg T.C. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta. J Cell Biochem 2003, 90:315-326.
62. Monroe D.G., Secreto F.J., Subramaniam M., Getz B.J., Khosla S., Spelsberg T.C. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells. Mol Endocrinol 2005, 19:1555-1568.
63. Wang C.H., Lee Y.S., Lin S.J., et al. Surface markers of heterogeneous peripheral blood-derived smooth muscle progenitor cells. Arterioscler Thromb Vasc Biol 2012, 32:1875-1883.
64. Jeong J.A., Ko K.M., Park H.S., et al. Membrane proteomic analysis of human mesenchymal stromal cells during adipogenesis. Proteomics 2007, 7:4181-4191.
65. Bujalska I.J., Quinkler M., Tomlinson J.W., Montague C.T., Smith D.M., Stewart P.M. Expression profiling of 11beta-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes. J Mol Endocrinol 2006, 37:327-340.
66. Denis C.J., Van Acker N., De Schepper S., et al. Mapping of carboxypeptidase M in normal human kidney and renal cell carcinoma: expression in tumor-associated neovasculature and macrophages. J Histochem Cytochem 2012, 10.1369/0022155412470456.
67. Salgado A.J., Reis R.L., Sousa N.J., Gimble J.M. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010, 5:103-110.
68. Wang P., Mariman E., Keijer J., et al. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci 2004, 61:2405-2417.
69. Molina H., Yang Y., Ruch T., et al. Temporal profiling of the adipocyte proteome during differentiation using a five-plex SILAC based strategy. J Proteome Res 2009, 8:48-58.
70. Kratchmarova I., Kalume D.E., Blagoev B., et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002, 1:213-222.
71. Lim J.M., Sherling D., Teo C.F., Hausman D.B., Lin D., Wells L. Defining the regulated secreted proteome of rodent adipocytes upon the induction of insulin resistance. J Proteome Res 2008, 7:1251-1263.
72. Choi S., Kim J., Yea K., Suh P.G., Kim J., Ryu S.H. Targeted label-free quantitative analysis of secretory proteins from adipocytes in response to oxidative stress. Anal Biochem 2010, 401:196-202.
73. Alvarez-Llamas G., Szalowska E., de Vries M.P., et al. Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics 2007, 6:589-600.
74. Roelofsen H., Dijkstra M., Weening D., de Vries M.P., Hoek A., Vonk R.J. Comparison of isotope-labeled amino acid incorporation rates (CILAIR) provides a quantitative method to study tissue secretomes. Mol Cell Proteomics 2009, 8:316-324.
75. Kang H.J., Kawasawa Y.I., Cheng F., et al. Spatio-temporal transcriptome of the human brain. Nature 2011, 478:483-489.
76. Jokay I., Soos G., Repassy G., Dezso B. Apoptosis in the human inner ear. Detection by in situ end-labeling of fragmented DNA and correlation with other markers. Hear Res 1998, 117:131-139.
77. Wanschura S., Kazmierczak B., Schoenmakers E., et al. Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15. Gene Chromosome Cancer 1995, 14:68-70.
78. Iwakuma T., Lozano G. MDM2, an introduction. Mol Cancer Res 2003, 1:993-1000.
79. Sreekantaiah C., Ladanyi M., Rodriguez E., Chaganti R.S. Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 1994, 144:1121-1134.
80. Unger K., Wienberg J., Riches A., et al. Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations. Endocr Relat Cancer 2010, 17:87-98.
81. Hahn Y., Bera T.K., Gehlhaus K., Kirsch I.R., Pastan I.H., Lee B. Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases. Proc Natl Acad Sci U S A 2004, 101:13257-13261.
82. Bullerdiek J., de Ven WJM Van Schoenmakers HFPM, Mols R. Multiple-tumor aberrant growth genes 1996, [WO9625493 (A1)].
83. Weaver J., Downs-Kelly E., Goldblum J.R., et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol 2008, 21:943-949.
84. Pedeutour F., Forus A., Coindre J.M., et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Gene Chromosome Cancer 1999, 24:30-41.
85. Macarenco R.S., Erickson-Johnson M., Wang X., et al. Retroperitoneal lipomatous tumors without cytologic atypia: are they lipomas? A clinicopathologic and molecular study of 19 cases. Am J Surg Pathol 2009, 33:1470-1476.
86. Zhang H., Erickson-Johnson M., Wang X., et al. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors. Am J Surg Pathol 2010, 34:1304-1311.
87. Tsakiris I., Torocsik D., Gyongyosi A., et al. Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells. Lab Invest 2012, 92:345-361.
88. Kovacs J., Varga A., Bessenyei M., Gomba S. Renal cell cancer associated with sarcoid-like reaction. Pathol Oncol Res 2004, 10:169-171.
89. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
90. Sica A., Allavena P., Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett 2008, 267:204-215.
91. Fujiwara N., Ikeda M., Hirabayashi S., et al. Monoclonal antibody 7F9 recognizes rat protein homologous to human carboxypeptidase-M in developing and adult rat lung. Respirology 2007, 12:54-62.
92. Skidgel R.A., Davis R.M., Tan F. Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem 1989, 264:2236-2241.
93. Baer P.C., Schubert R., Bereiter-Hahn J., Plosser M., Geiger H. Expression of a functional epidermal growth factor receptor on human adipose-derived mesenchymal stem cells and its signaling mechanism. Eur J Cell Biol 2009, 88:273-283.
94. Kurosu H., Kuro O.M. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol Cell Endocrinol 2009, 299:72-78.
95. Rega G., Kaun C., Demyanets S., et al. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol 2007, 27:1587-1595.
96. Lee Y.H., Martin J.M., Maple R.L., Tharp W.G., Pratley R.E. Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals. Neuroendocrinol 2009, 90:383-390.
97. Lopatina T., Kalinina N., Karagyaur M., et al. Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo. PLoS One 2011, 6:e17899.
98. Baxter R.C., Twigg S.M. Actions of IGF binding proteins and related proteins in adipose tissue. Trends Endocrinol Metab 2009, 20:499-505.
99. Nakao N., Nakayama T., Yahata T., et al. Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo: advantages over bone marrow-derived mesenchymal stem cells. Am J Pathol 2010, 177:547-554.
100. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:49-54.
101. Overall C.M., Tam E.M., Kappelhoff R., et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol Chem 2004, 385:493-504.
102. Schwartz D.R., Kardia S.L., Shedden K.A., et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 2002, 62:4722-4729.
103. Tsuda H., Ito Y.M., Ohashi Y., et al. Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses. Clin Cancer Res 2005, 11:6880-6888.
104. Haider A.S., Peters S.B., Kaporis H., et al. Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 2006, 126:869-881.
105. Francis P., Namlos H.M., Muller C., et al. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics 2007, 8:73.
106. Deddish P.A., Dragovic T., Erdos E.G., Weber G. High concentration of neutral endopeptidase (enkephalinase E.C. 3.4.24.11) in a malignant tumor: rat hepatoma 3924A. Biochem Biophys Res Commun 1990, 169:81-86.
107. Hockley S.L., Arlt V.M., Brewer D., Giddings I., Phillips D.H. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2. BMC Genomics 2006, 7:260.
108. Johnson S.K., Dennis R.A., Barone G.W., Lamps L.W., Haun R.S. Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray. Mol Carcinog 2006, 45:814-827.
109. Kannan K., Amariglio N., Rechavi G., et al. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 2001, 20:2225-2234.
110. Cohen A.J., Skidgel R.A., Gilman L.B., et al. Carboxypeptidase M. Variable expression in normal human lung and inactivation in lung cancer. Chest 1997, 111:149S.
111. Rizzatti E.G., Falcao R.P., Panepucci R.A., et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol 2005, 130:516-526.
112. Thuerigen O., Schneeweiss A., Toedt G., et al. Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. J Clin Oncol 2006, 24:1839-1845.